In line with findings in Rag1−/− mice, elimination of CD8+ T cells did not affect tumor response to DCP-IL-12/FLT3L and, remarkably, simultaneous elimination of CD8+ T cells, CD4+ T cells and NK1.1+ NK cells only moderately rescued tumor growth (Fig. 4j). The gene discussed is CD8A; the disease is neoplasm.